Business
Assessing Liver Fibrosis in Type 2 Diabetes Mellitus Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: The Role of Non-invasive Scoring Systems and Associated Factors - Cureus
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) constitutes a significant cause of chronic liver disease globally. Type 2 diabetes mellitus (T2DM) is a crucial risk factor for MASLD. This investigation is aimed at asses
By: Cureus.com
- Jun 16 2024
- 0
- 0 Views
Enter your email address to receive your free PDF download.
Please note that by doing so you agree to be added to our monthly email newsletter distribution list.